Aconsultant Mohammed Azeem
Sentencing for the former American Therapeutics consultant, originally scheduled for April 23 in Baltimore federal court, has been postponed until June 5. Azeem pleaded guilty on March 16 to one count of interstate travel in aid of racketeering and one count of offering an illegal gratuity to an FDA employee.
You may also be interested in...
The blockbuster drug is expected to see overall sales declines in the next few years, and biosimilar competition could come as soon as 2023.
Plus deals involving WuXi AppTec/OXGENE, Oscotec/Beatica, ReViral/LianBio, Wugen/HCW Biologics, Starton/Haisco, Shanghai Junshi/AstraZeneca, HitGen/Uppthera, Bridge/LegoChem, Macrogen/Lifex, BeiGene/Boston Immune